Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results

BACKGROUND: We evaluated the health-related quality of life (HRQoL) benefits of upadacitinib (UPA) induction and maintenance treatment in a phase 3 study of patients with ulcerative colitis (UC) across a broad range of patient-centered outcomes. METHODS: Patients received UPA 45 mg once daily or pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Panés, Julian, Loftus, Edward V, Higgins, Peter D R, Lindsay, James O, Zhou, Wen, Yao,, Xuan, Ilo, Dapo, Phillips, Charles, Tran, Jacinda, Sanchez Gonzalez, Yuri, Vermeire, Séverine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472742/
https://www.ncbi.nlm.nih.gov/pubmed/36645051
http://dx.doi.org/10.1093/ibd/izac260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472742/
https://www.ncbi.nlm.nih.gov/pubmed/36645051
http://dx.doi.org/10.1093/ibd/izac260

Ejemplares similares